Tag: Next Science

4 leading surgeons discuss surgical wound infections (video)

Medtech company Next Science has released video of a popular panel discussion it sponsored at the recent AAOS Annual Meeting. The 28-minute video can be viewed below or on youtube

The presentation, “Biofilm and Surgical Site Infections,” features insights from four leading orthopedic surgeons:
– Dr. Robert M. Harris, Hughston Clinic (Columbus, GA)
– Dr. Jon E. Minter, Northside Hospital (Atlanta, GA)
– Dr. Randall Otto, SSM Health (St. Louis, MO)
– Dr. Ravi K. Bashyal, NorthShore University Hospital (Chicago, IL)
Each year, there are about 1.5 million surgical site infections (SSIs) in the U.S., and patients with SSIs are five times more likely to be readmitted and twice as likely to die. SSIs also contribute an additional $3.5 billion annually to the cost of healthcare.

Next Science: Products that help treat wounds

Founded by scientist Matthew Myntti, the company develops products to reduce biofilm-based infections, which can be fatal.

As a scientist at Medtronic’s Jacksonville office working on chronic infections, Matthew Myntti said he began to understand the life-threatening nature of chronic wounds, and the infections that come with them.

He left the medical technology company in 2012 to start his own research focused on treating chronic wounds and keeping them from becoming infected … read more

Next Science Product Featured in Lifetime Channel Program on Treating Chronic Wounds

Next Science (ASX:NXS), an innovative medical technology company and leader in treating biofilm-based infections in humans, today announced new educational broadcast content about chronic infections, which impact 17 million Americans each year. “The Balancing Act,” a lifestyle show that airs on the Lifetime channel, will feature a segment that discusses the costly and debilitating nature of these infections and how physicians can more effectively treat patients suffering from chronic wounds, including diabetic wounds, by using BLASTX, Next Science’s antimicrobial wound gel … In addition to treating diabetic foot and leg ulcers, BLASTX can also be used for stage I-V pressure ulcers, partial- and full-thickness wounds, post-surgical wounds, first and second degree burns, and grafted and donor sites. BLASTX, which uses Next Science’s patented XBIO® Technology, which physically deconstructs the protective shell over the bacterial biofilm matrix, destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment. BLASTX is non-toxic and lasts up to five days … read more